الإحصائيات الأساسية
| LEI | 5299001DJ6C90XX17G45 |
| CIK | 57725 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Lannett Co., Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| June 20, 2023 |
Exhibit 99.1 Contact:[email protected] Lannett Successfully Emerges from Chapter 11 in Significantly Stronger Financial Position as the Company Remains on Track Toward Commercialization of Highly Promising Pipeline Plan of Reorganization Supported by All Major Creditor Constituencies Transaction Reduces Company’s Debt by Approximately $600 Million Emerges as a Private Company with New Bo |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
15-12G 1 tm2318955d11512g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-31298 LANNETT COMPANY, INC. (Exact |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2023 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 S-8 POS 1 tm2318961d1s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. 333-262534 333-253361 333-230461 333-193509 333-172304 333-147410 333-103236 333-103235 033-79258 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-262534 Post-Effective Amendment No |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. |
|
| June 20, 2023 |
As filed with the Securities and Exchange Commission on June 20, 2023 POS AM 1 tm2318965d1posam.htm POS AM As filed with the Securities and Exchange Commission on June 20, 2023 Registration Statement No. 333-255866 333-235640 333-223015 333-217964 333-191553 333-184721 333-162318 333-115746 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO: FORM S-3 REGISTRATION STATEMENT NO. 333-255866 FORM S-3 REGISTRATION STATEMENT NO. 33 |
|
| June 13, 2023 |
IN THE UNITED STATES BANKRUPTCY COURT FOR the district of delaware Exhibit 2.1 IN THE UNITED STATES BANKRUPTCY COURT FOR the district of delaware ) In re: ) Chapter 11 ) LANNETT COMPANY, INC., et al.,1 ) Case No. 23-10559 (JKS) ) Debtors. ) (Jointly Administered) ) ) Re: Docket Nos. 16, 17, 18, 52, 59, 119, 182, 220 FINDINGS OF fACT, CONCLUSIONS OF LAW, AND order (I) APPROVING THE DISCLOSURE STATEMENT FOR, AND CONFIRMING, THE AMENDED JOINT PREPACKAGED CHAPTER 11 |
|
| June 13, 2023 |
Financial Statements and Exhibits, Bankruptcy or Receivership UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2023 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. E |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-31298 L |
|
| May 15, 2023 |
Updated and Amended Certificate of Incorporation Exhibit 3.9 I, MICHAEL HARKINS, SECRETARY OF STATE OF THE STATE OF DELAWARE DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF INCORPORATION OF “LANNETT COMPANY, INC.” FILED IN THIS OFFICE ON THE THIRD DAY OF DECEMBER, A.D. 1991, AT 10:30 O’CLOCK A.M. * * * * * * * * * * * Certificate of incorporation Of Lannett company, inc. THE UNDERSIGNED, in order to form a corpora |
|
| May 4, 2023 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange ("NYSE" or the "Exchange") hereby notifies the Securities and Exchange Commission (the "Commission") of its intention to remove the entire class of Common Stock (the "Common Stock") of Lannett Company, Inc. |
|
| May 3, 2023 |
Exhibit 99.1 Contact: C Street Advisory Group [email protected] Lannett Company, Inc. Files Prepackaged Chapter 11 Cases to Significantly Strengthen Financial Position Restructuring Support Agreement Supported by Holders of More than 80% of the Company’s Senior Secured Notes and 100% of Holders of Second Lien Term Loan Restructuring Transactions Will Reduce the Company’s Funded Debt by Approx |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2023 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. Em |
|
| May 2, 2023 |
IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE ) In re: ) Chapter 11 ) LANNETT COMPANY, INC., et al.,1 ) Case No. 23-[] () ) Debtors. ) (Joint Administration Requested) ) Disclosure Statement for the Joint Prepackaged Chapter 11 Plan of Reorganization of LANNETT COMPANY, INC. AND ITS DEBTOR AFFILIATES THIS IS A SOLICITATION OF VOTES TO ACCEPT OR REJECT THE PLAN IN |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2023 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. Em |
|
| May 1, 2023 |
EX-10.1 2 tm2314233d1ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Execution Version THIS RESTRUCTURING SUPPORT AGREEMENT AND THE DOCUMENTS ATTACHED HERETO COLLECTIVELY DESCRIBE A PROPOSED RESTRUCTURING OF THE COMPANY PARTIES THAT WILL BE EFFECTUATED THROUGH FILING Prepackaged CHAPTER 11 CASES IN THE BANKRUPTCY COURT (AS DEFINED BELOW). THIS RESTRUCTURING SUPPORT AGREEMENT IS NOT AN OFFER, ACCEPTANCE, OR S |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2023 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| May 1, 2023 |
Exhibit 99.1 Contact: C Street Advisory Group [email protected] Lannett Company, Inc. Enters Into Restructuring Support Agreement Restructuring Support Agreement Supported by Holders of More Than 80% of the Company’s Senior Secured Notes and 100% of the Company’s Second Lien Term Loans Transaction Will Significantly Strengthen the Company’s Financial Position by Eliminating Approximately $511 |
|
| May 1, 2023 |
Letter Agreement dated as of April 30, 2023, by and among Lannett Company, Inc. and Timothy C. Crew Exhibit 10.2 April 30, 2023 Dear Mr. Crew: Reference is made to the 2023 Short-Term Incentive Plan (“Plan”) of the Company. Capitalized terms not otherwise defined in this letter agreement have the meaning set forth in that certain Restructuring Support Agreement, entered into and dated as of April 30, 2023, by and among the Debtors and the Consenting Stakeholders, including all exhibits, schedule |
|
| April 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 19, 2023 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| April 20, 2023 |
Exhibit 99.1 Contact: C Street Advisory Group [email protected] NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGS Company Expects No Impact on Operations Negotiations with Key Secured Creditors Progressing Toward a Balance Sheet Strengthening Transaction TREVOSE, PA – APRIL 20, 2023 – Lannett Company, Inc. (LCI) (“Lannett” or “the Company”) |
|
| April 14, 2023 |
Exhibit 10.103 SEPARATION AGREEMENT AND GENERAL RELEASE THIS SEPARATION AGREEMENT AND GENERAL RELEASE (hereinafter referred to as the “Agreement”) is made and entered into by and between John Kozlowski (as used herein, “Executive” includes John Kozlowski and his legal representatives, spouse, agents, heirs, executors, administrators, successors and assigns), and Lannett Company, Inc., its division |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2023 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| April 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2023 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| April 4, 2023 |
Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT shares update Announces Positive Results from Pivotal Clinical Insulin Trial that Demonstrates Biosimilarity to Reference Product Productive Conversations with Key Secured Creditors Toward a Balance Sheet Strengthening, Recapitalization or Restructuring Transaction Ongoing As Company Enters Grace Period for Failure to |
|
| February 10, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Lannett Company, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 516012101 (CUSIP Number) December 31, 2022 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant |
|
| February 7, 2023 |
Certificate of Amendment to the Certificate of Incorporation of Lannett Company, Inc. Exhibit 10.102 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF LANNETT COMPANY, INC. LANNETT COMPANY, INC., a corporation organized and existing under and by virtue of the Delaware General Corporation Law, DOES HEREBY CERTIFY: 1. The name of this corporation is Lannett Company, Inc. and the date on which the Certificate of Incorporation of this corporation was originally filed with |
|
| February 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): February 6, 2023 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| February 2, 2023 |
Sublicense Agreement between Lannett Company, Inc. and Ypsomed AG Exhibit 10.101 CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS AGREEMENT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. SUBLICENSE AGREEMENT between Lannett Company Inc., 1150 Northbrook Drive, Suite 155, Trevose, PA 19053 - “Lannett” - and Ypsomed AG, Brunnmattstrasse 6, CH-3401 Burgdo |
|
| February 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-3129 |
|
| February 2, 2023 |
LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCE Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCE Q2 Business and Financial Highlights: · Net Sales were $80.9 Million · Gross Margin was 18%, Adjusted Gross Margin was 19% · Net Sales, Gross Margin and Adjusted Gross Margin Up Versus Preceding Two Quarters · $19 Million Income Ta |
|
| February 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): February 1, 2023 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| January 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): January 25, 2023 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| December 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): December 15, 2022 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I. |
|
| November 29, 2022 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 [X] Filed by the Registrant [ ] Filed by a Party other than the Registrant Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a–6(e)(2)) |
|
| November 14, 2022 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2022 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R. |
|
| November 10, 2022 |
Table of Contents ? ? SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? ? SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ? [X] Filed by the Registrant [ ] Filed by a Party other than the Registrant ? Check the appropriate box: ? [X] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule |
|
| November 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-312 |
|
| November 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): November 2, 2022 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| November 3, 2022 |
Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT REPORTS BETTER THAN EXPECTED FINANCIAL RESULTS FOR FISCAL 2023 FIRST-QUARTER; REITERATES FULL-YEAR GUIDANCE Q1 Business and Financial Highlights: ? Net Sales were $75.1 Million ? Gross Margin 17%, Adjusted Gross Margin 18% ? Net Sales, Gross Margin and Adjusted Gross Margin Increased from Preceding Quarter ? Cash Was $ |
|
| August 25, 2022 |
LANNETT REPORTS FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT REPORTS FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS Q4 Business and Financial Highlights: ? Net Sales were $74.2 Million ? Adjusted Gross Margin Better than Expected, Improved vs Q3 ? Cash Was $88 Million at June 30 ? Completed Major Elements of November 2021 Restructuring Plan Pipeline Updates: ? Pivotal B |
|
| August 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): August 24, 2022 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R. |
|
| August 25, 2022 |
Form of Retention Award Letter ? Exhibit 10.100 ? Personal and Confidential ? September 1, 2022 Re: Retention Bonus Dear [NAME OF EXECUTIVE]: ? On behalf of Lannett Company, Inc. (the ?Company?), I am pleased to offer you the opportunity to receive a retention bonus if you agree to the terms and conditions contained in this letter agreement (this ?Agreement?), which shall be effective as of the date you execute and return a cop |
|
| August 25, 2022 |
Exhibit 21.1 Subsidiaries of the Company The following list identifies the subsidiaries of the Company: Subsidiary Name State of Incorporation Cody Laboratories, Inc. Wyoming Silarx Pharmaceuticals, Inc. New York Kremers Urban Pharmaceuticals, Inc. Indiana ? |
|
| August 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 3, 2022 |
LCI / Lannett Company, Inc. / JPMORGAN CHASE & CO - FILING LANNETT COMPANY, INC. Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 03)* LANNETT COMPANY, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 516012101 (CUSIP Number) May 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| May 31, 2022 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): March 28, 2022 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S |
|
| May 10, 2022 |
Exhibit 10.99 CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. MANUFACTURE AND SUPPLY AGREEMENT THIS MANUFACTURE AND SUPPLY AGREEMENT (this ?Agreement?) is made this 3rd day of March, 2022, by and between CHARTWELL PHARMACEUTICALS CA |
|
| May 10, 2022 |
? Exhibit 10.97 ? CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. ? 154 Contract of sale for New York office, commercial and multi-family Distributed by Julius Blumberg, Inc. residential premises. 7-06 NYC 10013 ? Prepared by the Re |
|
| May 10, 2022 |
? ? Exhibit 10.98 CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS AGREEMENT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (this ?Agreement?) is made and entered into as of March 3, 2022, by and between CHARTWELL CARMEL ASSETS, LLC, |
|
| May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): May 4, 2022 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. E |
|
| May 5, 2022 |
LANNETT REPORTS FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT REPORTS FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTS Q3 Business and Financial Highlights: ? Net Sales were $78.4 Million ? Cash in Excess of $106 Million at March 31 ? Completed Sale of Liquid Manufacturing Plant for $10.5 Million; Major Elements of November 2021 Restructuring Plan Expected to be Completed by June 30 ? |
|
| March 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): March 14, 2022 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S |
|
| March 18, 2022 |
LANNETT announces receipt of notice of non-compliance from nyse related to stock price Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT announces receipt of notice of non-compliance from nyse related to stock price Trevose, PA ? March 18, 2022 ? Lannett Company, Inc. (NYSE: LCI) today announced that it has received written notice from the New York Stock Exchange (NYSE) dated March 14, 2022, notifying the company that it is not in compliance with the co |
|
| March 4, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(D) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2022 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| March 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): March 2, 2022 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| March 4, 2022 |
Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT Announces sale of liquid drug manufacturing plant and other assets for $10.5 million -Transaction a Key Element of Company?s Plan to Streamline Operations and Reduce Costs; Proceeds Further Strengthens Cash Position- Philadelphia, PA ? March 4, 2022 ? Lannett Company, Inc. (NYSE: LCI) today announced that it has entere |
|
| March 4, 2022 |
LANNETT announces receipt of notice of non-compliance from nyse Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT announces receipt of notice of non-compliance from nyse Philadelphia, PA ? March 4, 2022 ? Lannett Company, Inc. (NYSE: LCI) today announced that it has received written notice from the New York Stock Exchange (NYSE) dated March 2, 2022, notifying the company that it is not in compliance with the continued listing stan |
|
| February 11, 2022 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Lannett Company, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 516012101 (CUSIP Number) December 31, 2021 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant |
|
| February 10, 2022 |
LCI / Lannett Company, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Lannett Co. Inc. Title of Class of Securities: Common Stock CUSIP Number: 516012101 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Ru |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 4, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Lannett Company, Inc. |
|
| February 4, 2022 |
As filed with the Securities and Exchange Commission on February 4, 2022 As filed with the Securities and Exchange Commission on February 4, 2022 Registration No. |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): February 3, 2022 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| February 4, 2022 |
LANNETT REPORTS FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS; REVISES DOWN FULL-YEAR GUIDANCE Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT REPORTS FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS; REVISES DOWN FULL-YEAR GUIDANCE ? Q2 Business and Financial Highlights: ? Net Sales were $86.5 Million ? Negative Adjusted EBITDA was $1.0 Million ? Cash in Excess of $98 Million at December 31 ? November 2021 Restructuring Plan Initiatives On Track ? Biosimilar Ins |
|
| January 27, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): January 26, 2022 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| January 20, 2022 |
Third Addendum to Employment Agreement of Maureen Cavanaugh Exhibit 10.94 THIRD ADDENDUM to Employment Agreement of Maureen Cavanaugh This Third Addendum (the ?Third Addendum?) to the Employment Agreement of Maureen Cavanaugh is entered into as of this 17th day of January 2022, between Lannett Company, Inc. (the ?Company?) and Maureen Cavanaugh (?Ms. Cavanaugh?) (together, the Company and Ms. Cavanaugh shall be known as the ?Parties?). RECITALS WHEREAS, Ms |
|
| January 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2022 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R. |
|
| January 20, 2022 |
Fourth Addendum to Employment Agreement of Timothy Crew Exhibit 10.92 FOURTH ADDENDUM to Employment Agreement of Timothy Crew This Fourth Addendum (the ?Fourth Amendment?) to the Employment Agreement of Timothy Crew, is entered into as of this 17th day of January 2022, between Lannett Company, Inc. (the ?Company?) and Timothy Crew (?Mr. Crew?) (together, the Company and Mr. Crew shall be known as the ?Parties?). RECITALS WHEREAS, Mr. Crew entered into |
|
| January 20, 2022 |
Third Addendum to Employment Agreement of John Abt Exhibit 10.96 THIRD ADDENDUM to Employment Agreement of John Abt This Third Addendum (the ?Third Addendum?) to the Employment Agreement of John Abt is entered into as of this 17th day of January 2022, between Lannett Company, Inc. (the ?Company?) and John Abt (?Mr. Abt?) (together, the Company and Mr. Abt shall be known as the ?Parties?). RECITALS WHEREAS, Mr. Abt entered into an Employment Agreem |
|
| January 20, 2022 |
Fourth Amendment to Restated Employment Agreement of John Kozlowski Exhibit 10.93 FOURTH AMENDMENT to Restated Employment Agreement of John Kozlowski This Fourth Amendment (the ?Fourth Amendment?) to the Restated Employment Agreement of John Kozlowski, is entered into as of this 17th day of January 2022, between Lannett Company, Inc. (the ?Company?) and John Kozlowski (?Mr. Kozlowski?) (together, the Company and Mr. Kozlowski shall be known as the ?Parties?). RECI |
|
| January 20, 2022 |
Third Addendum to Employment Agreement of Samuel H. Israel EX-10.95 5 tm223336d1ex10-95.htm EXHIBIT 10.95 Exhibit 10.95 THIRD ADDENDUM to Employment Agreement of Samuel H. Israel This Third Addendum (the “Third Addendum”) to the Employment Agreement of Samuel H. Israel is entered into as of this 17th day of January 2022, between Lannett Company, Inc. (the “Company”) and Samuel H. Israel (“Mr. Israel”) (together, the Company and Mr. Israel shall be known a |
|
| January 12, 2022 |
LCI / Lannett Company, Inc. / JPMORGAN CHASE & CO - FILING LANNETT COMPANY, INC. Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* LANNETT COMPANY, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 516012101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| December 10, 2021 |
Table of Contents ? ? SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? ? SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ? [X] Filed by the Registrant [ ] Filed by a Party other than the Registrant ? Check the appropriate box: ? [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only ? (as permitted by Ru |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): November 3, 2021 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 4, 2021 |
Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT REPORTS FISCAL 2022 FIRST-QUARTER FINANCIAL RESULTS; REVISES DOWN FULL-YEAR GUIDANCE -Company Announces Restructuring Plan Targeting $20 Million in Reduced Expenses, To Consolidate Manufacturing Operations and Restructure the R&D Function- ? Q1 Business and Financial Highlights: ? Net Sales were $102 Million, Exceeding |
|
| August 26, 2021 |
LANNETT ANNOUNCES FISCAL 2021 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES FISCAL 2021 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS ? Q4 Business and Financial Highlights: ? Net Sales Were $106 Million ? Cash Increased to Over $93 Million at June 30 ? ANDA for Generic ADVAIR DISKUS? Submitted, Accepted for Priority Review ? Completed Re-financing Transaction, Debt Maturity Extended t |
|
| August 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): August 25, 2021 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R. |
|
| August 26, 2021 |
Exhibit 21.1 Subsidiaries of the Company The following list identifies the subsidiaries of the Company: Subsidiary Name State of Incorporation Lannett Holdings, Inc. Delaware Cody Laboratories, Inc. Wyoming Silarx Pharmaceuticals, Inc. New York Kremers Urban Pharmaceuticals, Inc. Indiana ? |
|
| August 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 26, 2021 |
Distribution Agreement Between Respirent Pharmaceuticals Co. Ltd. and Lannett Company, Inc. ? Exhibit 10.90 CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. DISTRIBUTION AGREEMENT THIS DISTRIBUTION AGREEMENT (this ?Agreement?) is made this 26th day of September, 2019 (the ?Effective Date?), by and between Respirent Pharmace |
|
| August 26, 2021 |
? Exhibit 10.91 CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. AMENDMENT NO. 1 TO DISTRIBUTION AGREEMENT BETWEEN RESPIRENT PHARMACEUTICALS CO. LTD. AND LANNETT COMPANY, INC. ? This Amendment No. 1 to the Distribution Agreement (the |
|
| May 27, 2021 |
PROSPECTUS 8,280,000 Shares of Common Stock Filed Pursuant to Rule 424(B)(3) Registration No. 333-255866 PROSPECTUS 8,280,000 Shares of Common Stock This prospectus relates to the resale, from time to time, of up to an aggregate of 8,280,000 shares of common stock, par value $0.001 per share, of Lannett Company, Inc. by the selling stockholders named in this prospectus, including their respective transferees, assignees or other successors-i |
|
| May 25, 2021 |
May 25, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attn: Alan Campbell Re: ????? Lannett Company, Inc. |
|
| May 7, 2021 |
As filed with the Securities and Exchange Commission on May 7, 2021 Registration No. |
|
| May 6, 2021 |
EXECUTION VERSION CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. |
|
| May 6, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): May 5, 2021 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. E |
|
| May 6, 2021 |
LANNETT ANNOUNCES FISCAL 2021 THIRD-QUARTER FINANCIAL RESULTS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES FISCAL 2021 THIRD-QUARTER FINANCIAL RESULTS ? Q3 Business and Financial Highlights: ? Net Sales Were $112 Million ? Adjusted Gross Margin, Adjusted Profitability Better than Expected ? Cash Significantly Increased to More Than $80 Million ? Full-Year Adjusted Top- and Bottom-Line Guidance Reiterated ? Added A |
|
| May 6, 2021 |
Supply Agreement by and among Lannett Company, Inc. and Sunshine Lake Pharma Co., Ltd. EXECUTION VERSION CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. |
|
| April 26, 2021 |
Exhibit 10.85 Execution Version SECOND LIEN PLEDGE AND SECURITY AGREEMENT, dated as of April 22, 2021, among LANNETT COMPANY, INC., as the Borrower, each Guarantor from time to time party hereto, and ALTER DOMUS (US) LLC, as Administrative Agent and Collateral Agent Pledge and Security Agreement TABLE OF CONTENTS Page Article I. DEFINITIONS 1 Section 1.01 Credit Agreement 1 Section 1.02 Other Defi |
|
| April 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2021 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| April 26, 2021 |
Exhibit 10.84 EXECUTION VERSION NOTES PLEDGE AND SECURITY AGREEMENT, dated as of April 22, 2021, among LANNETT COMPANY, INC., as the Issuer, each Guarantor from time to time party hereto, and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Collateral Agent and Trustee Pledge and Security Agreement TABLE OF CONTENTS Page Article I. DEFINITIONS 1 Section 1.01 Indenture 1 Section 1.02 Other Defined Terms |
|
| April 26, 2021 |
Exhibit 4.6 SUPPLEMENTAL INDENTURE ESTABLISHING A SERIES OF NOTES LANNETT COMPANY, INC. as Issuer and the Subsidiary Guarantors from time to time party to the Indenture and WILMINGTON TRUST, NATIONAL ASSOCIATION as Trustee FIRST SUPPLEMENTAL INDENTURE DATED AS OF APRIL 22, 2021 7.750% Senior Secured Notes Due 2026 FIRST SUPPLEMENTAL INDENTURE, dated as of April 22, 2021 (this ?Supplemental Indentu |
|
| April 26, 2021 |
Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT Announces closing of $350 million Senior secured Notes and $190 Million second lien senior secured loan facility -Transaction Proceeds Used to Retire Company?s Term Loan B Due 2022- Philadelphia, PA ? April 22, 2021 ? Lannett Company, Inc. (NYSE: LCI) today announced the closing of the $350 million aggregate principal |
|
| April 26, 2021 |
Exhibit 4.5 EXECUTION VERSION Lannett Company, Inc., as Company INDENTURE Dated as of April 22, 2021 Wilmington Trust, National Association, as Trustee and Note Collateral Agent PROVIDING FOR THE ISSUANCE OF NOTES IN SERIES Table of Contents Page ARTICLE I Definitions and Incorporation by Reference 1 SECTION 1.1 Definitions 1 SECTION 1.2 Other Definitions 52 SECTION 1.3 Rules of Construction 54 SE |
|
| April 26, 2021 |
Exhibit 10.87 Execution Version AMENDMENT NUMBER ONE TO CREDIT AND GUARANTY AGREEMENT AND PLEDGE AND SECURITY AGREEMENT THIS AMENDMENT NUMBER ONE TO CREDIT AND GUARANTY AGREEMENT AND PLEDGE AND SECURITY AGREEMENT (this ?Amendment?), effective as of April 22, 2021, is entered into by and among LANNETT COMPANY, INC, a Delaware corporation (?Parent Borrower?), the Subsidiary Borrowers party hereto (t |
|
| April 26, 2021 |
Form of Warrant to Purchase Common Stock. Exhibit 10.82 FORM OF WARRANT THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), OR ANY STATE SECURITIES LAW. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, EXCEPT PURSUANT TO AN EXEMPTION FROM REGISTRATION |
|
| April 26, 2021 |
Exhibit 10.81 EXECUTION VERSION SECOND LIEN CREDIT AND GUARANTY AGREEMENT dated as of April 22, 2021 among LANNETT COMPANY, INC., as the Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER, as Guarantors, THE LENDERS PARTY HERETO, and ALTER DOMUS (US) LLC as Administrative Agent and Collateral Agent ?????????????????????????? $190,000,000 Second Lien Term Loans ?????????????????????????? TABLE OF CONTE |
|
| April 26, 2021 |
Exhibit 10.83 Execution Version REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of April 22, 2021, by and among Lannett Company, Inc., a Delaware corporation (the ?Company?), Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P. and BPC Lending II LLC, (each individually, a ?Lender? and together, the ?Lenders?). WHEREAS: A. In connection wi |
|
| April 26, 2021 |
Exhibit 10.86 EXECUTION VERSION CASH FLOW INTERCREDITOR AGREEMENT by and between WILMINGTON TRUST, NATIONAL ASSOCIATION, as Cash Flow Agent and ALTER DOMUS (US) LLC, as Initial Junior Priority Agent dated as of April 22, 2021 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS Section 1.1 UCC Definitions 2 Section 1.2 Other Definitions 2 Section 1.3 Rules of Construction 22 ARTICLE II LIEN PRIORITY Secti |
|
| April 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2021 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| April 12, 2021 |
Exhibit 10.80 AMENDED AND RESTATED EXCHANGE AGREEMENT THIS AMENDED AND RESTATED EXCHANGE AGREEMENT (this ?Agreement?), dated as of April 8, 2021 (this ?Agreement?), is entered into by and among Lannett Company, Inc., a corporation organized under the laws of Delaware (the ?Borrower?), the BPC Funds (as defined herein), BPC Lending (as defined herein), Deerfield (as defined herein, and collectively |
|
| April 9, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2021 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| April 9, 2021 |
LANNETT Announces Pricing of $350 million Senior secured Notes Due 2026 Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT Announces Pricing of $350 million Senior secured Notes Due 2026 Philadelphia, PA ? April 9, 2021 ? Lannett Company, Inc. (NYSE: LCI) (the ?Company? or ?Lannett?) today announced the pricing of the $350 million aggregate principal amount of 7.75% senior secured notes due 2026 (the ?Notes?) in a private placement to qual |
|
| April 6, 2021 |
Exhibit 10.79 EXCHANGE AGREEMENT THIS EXCHANGE AGREEMENT (this ?Agreement?), dated as of April 5, 2021 (this ?Agreement?), is entered into by and among Lannett Company, Inc., a corporation organized under the laws of Delaware (the ?Borrower?) and the undersigned lenders under the Existing Term Loan Credit Agreement (as defined herein, and together with their successors and assigns, each in such ca |
|
| April 6, 2021 |
LANNETT Announces Offering of $350 million Senior secured Notes Due 2026 Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT Announces Offering of $350 million Senior secured Notes Due 2026 Philadelphia, PA ? April 6, 2021 ? Lannett Company, Inc. (NYSE: LCI) (the ?Company?) today announced that it intends to offer, subject to market conditions and other factors, $350 million aggregate principal amount of senior secured notes due 2026 (the ?N |
|
| April 6, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2021 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| April 6, 2021 |
Exhibit 99.1 INVESTOR PRESENTATION April 2021 ? 2021 Lannett Company, Inc. All Rights Reserved. For Discussion Purposes Only 1 This presentation contains forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regarding our future results of operations and financial position, business strategy and plans and objectives |
|
| April 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2021 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| April 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2021 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| February 22, 2021 |
As filed with the Securities and Exchange Commission on February 22, 2021 Registration No. |
|
| February 16, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 4) Under the Securities Exchange Act of 1934 Lannett Company, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 516012101 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the following box to designate the rule pursuant to which the S |
|
| February 16, 2021 |
Exhibit 1 POWER OF ATTORNEY FOR CERTAIN REGULATORY FILINGS INCLUDING CERTAIN FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND THE INVESTMENT ADVISERS ACT OF 1940 I, David E. |
|
| February 16, 2021 |
Exhibit 2 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned Reporting Persons hereby agrees to the joint filing, along with all other such Reporting Persons, on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0. |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Lannett Co. Inc. Title of Class of Securities: Common Stock CUSIP Number: 516012101 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Ru |
|
| February 9, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Lannett Company, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 516012101 (CUSIP Number) December 31, 2020 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant |
|
| February 9, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(D) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2021 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R. |
|
| February 9, 2021 |
Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT EXPANDS STRATEGIC RELATIONSHIP TO INCLUDE BIOSIMILAR FAST-ACTING INSULIN -Lannett and HEC to Co-develop Insulin Aspart; Lannett Granted Exclusive US Commercialization Rights- Philadelphia, PA – February 9, 2021 – Lannett Company, Inc. (NYSE: LCI) today announced that it has added a new co-development agreement for bios |
|
| February 4, 2021 |
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***] HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. |
|
| February 4, 2021 |
EX-10.78 4 lci-20201231xex10d78.htm EX-10.78 Exhibit 10.78 AMENDMENT nO. 2 TO LICENSE AND SUPPLY AGREEMENT THIS AMENDMENT NO. 2 TO LICENSE AND SUPPLY AGREEMENT (this “Amendment”) is made as of November 5, 2020 by and between Recro Gainesville LLC (as successor to Alkermes Pharma Ireland Limited) (“Recro”), Kremers Urban Pharmaceuticals, Inc. (“Kremers Urban”) and Lannett Company, Inc. (“Lannett”). |
|
| February 4, 2021 |
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***] HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. |
|
| February 4, 2021 |
LANNETT ANNOUNCES FISCAL 2021 SECOND-QUARTER FINANCIAL RESULTS IN LINE OR ABOVE EXPECTATIONS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES FISCAL 2021 SECOND-QUARTER FINANCIAL RESULTS IN LINE OR ABOVE EXPECTATIONS Q2 Financial and Business Highlights: · Net Sales of $134 Million · Adjusted EBITDA of $24 Million · Paid Off, In Full, Term A Loans · Established New $30 Million Revolving Credit Facility Philadelphia, PA – February 3, 2021 – Lannett |
|
| February 4, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-3129 |
|
| February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): February 3, 2021 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| January 28, 2021 |
Submission of Matters to a Vote of Security Holders - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): January 27, 2021 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| January 25, 2021 |
Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* LANNETT COMPANY, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 516012101 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| January 14, 2021 |
Material Impairments, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2021 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R. |
|
| December 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2020 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| December 29, 2020 |
Fourth Addendum to Employment Agreement of Timothy C. Crew dated December 28, 2020 Exhibit 10.75 FOURTH ADDENDUM to Employment Agreement of Timothy Crew This Fourth Addendum (the “Fourth Addendum”) to the Employment Agreement of Timothy Crew, is entered into as of this 28th day of December, 2020, between Lannett Company, Inc. (the “Company”) and Timothy Crew (“Mr. Crew”) (together, the Company and Mr. Crew shall be known as the “Parties”). RECITALS WHEREAS, Mr. Crew entered into |
|
| December 10, 2020 |
Exhibit 10.72 EXECUTION VERSION INTERCREDITOR AGREEMENT by and between WELLS FARGO BANK, NATIONAL ASSOCIATION, as ABL Agent, and ALTER DOMUS (US) LLC as Term Loan Agent Dated as of December 7, 2020 Table of Contents Page ARTICLE 1 Definitions 2 Section 1.1 UCC Definitions 2 Section 1.2 Other Definitions 2 Section 1.3 Rules of Construction 28 ARTICLE 2 Lien Priority 28 Section 2.1 Agreement to Subo |
|
| December 10, 2020 |
Exhibit 10.70 CREDIT AND GUARANTY AGREEMENT dated as of December 7, 2020 among LANNETT COMPANY, INC. and THE SUBSIDIARY BORROWERS PARTY HERETO, as Borrowers, THE SUBSIDIARY GUARANTORS PARTY HERETO, THE LENDERS PARTY HERETO, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent and Collateral Agent ?????????????????????????? $30,000,000 Revolving Commitments ?????????????????????????? |
|
| December 10, 2020 |
Exhibit 10.73 INTELLECTUAL PROPERTY SECURITY AGREEMENT This INTELLECTUAL PROPERTY SECURITY AGREEMENT (this ?IP Security Agreement?) dated December 7, 2020, is made by the persons listed on the signature pages hereof (collectively, the ?Grantors?) in favor of Wells Fargo Bank, National Association, acting through one or more of its branches or any Affiliate thereof, as collateral agent (in such cap |
|
| December 10, 2020 |
Exhibit 10.74 EXECUTION VERSION AMENDMENT NO. 4 TO CREDIT AND GUARANTY AGREEMENT Dated December 7, 2020 among LANNETT COMPANY, INC., as the Borrower MORGAN STANLEY SENIOR FUNDING, INC., as Administrative Agent and Each Lender Party Hereto AMENDMENT NO. 4 TO CREDIT AND GUARANTY AGREEMENT This AMENDMENT NO. 4 TO CREDIT AND GUARANTY AGREEMENT, dated as of December 7, 2020 (this ?Amendment?), is made |
|
| December 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2020 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) Commission file no. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R. |
|
| December 10, 2020 |
Exhibit 10.71 PLEDGE AND SECURITY AGREEMENT, dated as of December 7, 2020, among LANNETT COMPANY, INC., as the Parent Borrower, each Guarantor from time to time party hereto, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent and Collateral Agent Pledge and Security Agreement Table of Contents Page Article I. DEFINITIONS 1 Section 1.01 Credit Agreement 1 Section 1.02 Other Defined |
|
| December 10, 2020 |
LANNETT ANNOUNCES NEW $30 MILLION REVOLVING CREDIT FACILITY Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES NEW $30 MILLION REVOLVING CREDIT FACILITY Philadelphia, PA ? December 7, 2020 ? Lannett Company, Inc. (NYSE: LCI) today announced the closing of a $30 million asset-backed revolving credit facility with Wells Fargo Bank, National Association. ?Completing this transaction enhances our financial flexibility, su |
|
| December 7, 2020 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 [X] Filed by the Registrant [ ] Filed by a Party other than the Registrant Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a–6(e)(2)) |
|
| November 12, 2020 |
Entry into a Material Definitive Agreement - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2020 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) Commission file no. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R. |
|
| November 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): November 4, 2020 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| November 5, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-312 |
|
| November 5, 2020 |
LANNETT ANNOUNCES FISCAL 2021 FIRST-QUARTER FINANCIAL RESULTS; AFFIRMS GUIDANCE Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES FISCAL 2021 FIRST-QUARTER FINANCIAL RESULTS; AFFIRMS GUIDANCE Financial and Business Highlights: · Q1 Net Sales of $126 Million · Q1 Adjusted EBITDA of $33 Million · Commenced Marketing Four Products in FY21 Q1 · Fully Implemented $15 Million of Cost Reduction Initiatives · Recently Announced the Marketing of |
|
| August 28, 2020 |
Second Addendum to Employment Agreement of Samuel H. Israel Exhibit 10.67 SECOND ADDENDUM to Employment Agreement of Samuel H. Israel This Second Addendum (the “Second Addendum”) to the Employment Agreement of Samuel H. Israel, is entered into as of this 24th day of August 2020, between Lannett Company, Inc. (the “Company”) and Samuel H. Israel (“Mr. Israel”) (together, the Company and Mr. Israel shall be known as the “Parties”). RECITALS WHEREAS, Mr. Isra |
|
| August 28, 2020 |
Third Addendum to Employment Agreement of Timothy Crew Exhibit 10.64 THIRD ADDENDUM to Employment Agreement of Timothy Crew This Third Addendum (the “Third Amendment”) to the Employment Agreement of Timothy Crew, is entered into as of this 24th day of August 2020, between Lannett Company, Inc. (the “Company”) and Timothy Crew (“Mr. Crew”) (together, the Company and Mr. Crew shall be known as the “Parties”). RECITALS WHEREAS, Mr. Crew entered into an E |
|
| August 28, 2020 |
Second Addendum to Amended and Restated Employment Agreement of Robert Ehlinger Exhibit 10.69 SECOND ADDENDUM to Amended and Restated Employment Agreement of Robert Ehlinger This Second Addendum (the “Second Addendum”) to the Amended and Restated Employment Agreement of Robert Ehlinger is entered into as of this 24th day of August 2020, between Lannett Company, Inc. (the “Company”) and Robert Ehlinger (“Mr. Ehlinger”) (together, the Company and Mr. Ehlinger shall be known as |
|
| August 28, 2020 |
Third Amendment to Restated Employment Agreement of John Kozlowski Exhibit 10.65 THIRD AMENDMENT to Restated Employment Agreement of John Kozlowski This Third Amendment (the “Third Amendment”) to the Restated Employment Agreement of John Kozlowski, is entered into as of this 24th day of August 2020, between Lannett Company, Inc. (the “Company”) and John Kozlowski (“Mr. Kozlowski”) (together, the Company and Mr. Kozlowski shall be known as the “Parties”). RECITALS |
|
| August 28, 2020 |
Second Addendum to Employment Agreement of John Abt Exhibit 10.68 SECOND ADDENDUM to Employment Agreement of John Abt This Second Addendum (the “Second Addendum”) to the Employment Agreement of John Abt is entered into as of this 24th day of August 2020, between Lannett Company, Inc. (the “Company”) and John Abt (“Mr. Abt”) (together, the Company and Mr. Abt shall be known as the “Parties”). RECITALS WHEREAS, Mr. Abt entered into an Employment Agre |
|
| August 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2020 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) Commission file no. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S |
|
| August 28, 2020 |
Second Addendum to Employment Agreement of Maureen Cavanaugh Exhibit 10.66 SECOND ADDENDUM to Employment Agreement of Maureen Cavanaugh This Second Addendum (the “Second Addendum”) to the Employment Agreement of Maureen Cavanaugh is entered into as of this 24th day of August 2020, between Lannett Company, Inc. (the “Company”) and Maureen Cavanaugh (“Ms. Cavanaugh”) (together, the Company and Ms. Cavanaugh shall be known as the “Parties”). RECITALS WHEREAS, |
|
| August 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): August 26, 2020 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R. |
|
| August 27, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ⌧ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 OR ◻ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-31298 LANNETT COMPANY, |
|
| August 27, 2020 |
Amendment to Sinotherapeutics Distribution and Supply Agreement CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. |
|
| August 27, 2020 |
LANNETT ANNOUNCES FISCAL 2020 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES FISCAL 2020 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS Financial and Business Highlights: · Q4 Net Sales of $138 Million, Exceeded Expectations · Q4 Adjusted EBITDA of $35 Million · Commenced Marketing Six Products in FY20 Q4, Four thus far in FY2021, including Levothyroxine Tablets · Implemented $15 Million |
|
| August 27, 2020 |
Exhibit 21.1 Subsidiaries of the Company The following list identifies the subsidiaries of the Company: Subsidiary Name State of Incorporation Lannett Holdings, Inc. Delaware Cody Laboratories, Inc. Wyoming Silarx Pharmaceuticals, Inc. New York Kremers Urban Pharmaceuticals, Inc. Indiana |
|
| August 17, 2020 |
NOTICE OF PROPOSED SETTLEMENT AND DISMISSAL WITH PREJUDICE OF DERIVATIVE ACTION Exhibit 99.1 NOTICE OF PROPOSED SETTLEMENT AND DISMISSAL WITH PREJUDICE OF DERIVATIVE ACTION TO: ALL OWNERS OF LANNETT COMPANY, INC. (“LANNETT” OR THE “COMPANY”) STOCK (TICKER SYMBOL: LCI). PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. THIS NOTICE RELATES TO A PROPOSED SETTLEMENT AND DISMISSAL WITH PREJUDICE OF STOCKHOLDER DERIVATIVE LITIGATION AND CONTAINS IMPORTANT INFORMATION REGARDING |
|
| August 17, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2020 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) Commission file no. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| August 17, 2020 |
IN THE United States District Court FOR THE DISTRICT OF DELAWARE Exhibit 99.2 IN THE United States District Court FOR THE DISTRICT OF DELAWARE IN RE LANNETT COMPANY, INC. DERIVATIVE LITIGATION Lead Case No.: 1:19-cv-00888-MN-JLH STIPULATION AND AGREEMENT OF SETTLEMENT This Stipulation and Agreement of Settlement dated May 22, 2020 (the “Stipulation”), is made and entered into by and among the following Parties (as defined below), each by and through their respe |
|
| July 20, 2020 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Lannett Company, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 516012101 (CUSIP Number) July 8, 2020 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to whic |
|
| July 14, 2020 |
LANNETT ANNOUNCES RESTRUCTURING, COST REDUCTION INITIATIVES Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES RESTRUCTURING, COST REDUCTION INITIATIVES Philadelphia, PA – July 13, 2020 – Lannett Company, Inc. (NYSE: LCI) today announced a restructuring and cost savings plan. The initiatives include consolidating the research and development (R&D) function into a single location in Philadelphia and lowering operating |
|
| July 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2020 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) Commission file no. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| June 10, 2020 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2020 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) Commission file no. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. E |
|
| May 7, 2020 |
LANNETT ANNOUNCES FISCAL 2020 THIRD-QUARTER FINANCIAL RESULTS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES FISCAL 2020 THIRD-QUARTER FINANCIAL RESULTS Financial and Business Highlights: · Q3 Net Sales of $144 Million, a Record, Post Levothyroxine · Adjusted EBITDA of $36 Million, In Line with Expectations · Commenced Marketing Four Products in FY20 Q3, Two Thus Far in Q4 Philadelphia, PA – May 6, 2020 – Lannett Co |
|
| May 7, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2020 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-31298 LAN |
|
| May 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): May 6, 2020 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. E |
|
| February 14, 2020 |
Exhibit 2 POWER OF ATTORNEY FOR CERTAIN REGULATORY FILINGS INCLUDING CERTAIN FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND THE INVESTMENT ADVISERS ACT OF 1940 I, David E. |
|
| February 14, 2020 |
LCI / Lannett Co., Inc. / D. E. SHAW & CO, L.P. - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 3) Under the Securities Exchange Act of 1934 Lannett Company, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 516012101 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the following box to designate the rule pursuant to which the S |
|
| February 14, 2020 |
Exhibit 1 POWER OF ATTORNEY FOR CERTAIN REGULATORY FILINGS INCLUDING CERTAIN FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND THE INVESTMENT ADVISERS ACT OF 1940 I, David E. |
|
| February 14, 2020 |
Exhibit 3 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned Reporting Persons hereby agrees to the joint filing, along with all other such Reporting Persons, on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0. |
|
| February 11, 2020 |
LCI / Lannett Co., Inc. / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Lannett Co Inc Title of Class of Securities: Common Stock CUSIP Number: 516012101 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d |
|
| February 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): February 5, 2020 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| February 7, 2020 |
LANNETT ANNOUNCES FISCAL 2020 SECOND-QUARTER FINANCIAL RESULTS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES FISCAL 2020 SECOND-QUARTER FINANCIAL RESULTS Financial and Business Highlights: · Q2 Net Sales Higher than Expected, Up Solidly from Q1 · Commenced Marketing Eight Products in FY20 First Half, Approximately 10 Additional Product Introductions Anticipated in Second Half · Launch Imminent for Numbrino®, Company |
|
| February 6, 2020 |
Exhibit 10.61 CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. COLLABORATION AND LICENSE AGREEMENT by and among LANNETT COMPANY, INC. and NORTH & SOUTH BROTHER PHARMACY INVESTMENT CO., LTD and HEC GROUP PTY LTD Dated as of November 2 |
|
| February 6, 2020 |
LCI / Lannett Co., Inc. 10-Q - Quarterly Report - 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2019 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-31298 |
|
| February 6, 2020 |
CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. |
|
| January 24, 2020 |
LCI / Lannett Co., Inc. / JP Morgan Chase & Co - FILING LANNETT COMPANY, INC. Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* LANNETT COMPANY, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 516012101 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| January 24, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): January 22, 2020 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| January 21, 2020 |
LCI / Lannett Co., Inc. CORRESP - - January 21, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attn: Chris Edwards Re: Lannett Company, Inc. |
|
| January 9, 2020 |
LCI / Lannett Co., Inc. CORRESP - - January 9, 2020 Division of Corporation Finance Office of Life Sciences United States Securities and Exchange Commission 100 F Street, NE Washington, D. |
|
| December 20, 2019 |
LCI / Lannett Co., Inc. S-3 - - S-3 Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on December 20, 2019 Registration No. |
|
| December 20, 2019 |
Exhibit 4.2 LANNETT COMPANY, INC. INDENTURE Dated as of [ ] Trustee TABLE OF CONTENTS Page ARTICLE I. DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1. Definitions 1 Section 1.2. Other Definitions 4 Section 1.3. Incorporation by Reference of Trust Indenture Act 5 Section 1.4. Rules of Construction 5 ARTICLE II. THE SECURITIES 5 Section 2.1. Issuable in Series 5 Section 2.2. Establishment o |
|
| December 6, 2019 |
LCI / Lannett Co., Inc. DEF 14A - - DEF 14A Table of Contents SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 [X] Filed by the Registrant [ ] Filed by a Party other than the Registrant Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a–6(e)(2)) |
|
| November 26, 2019 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 Or 15(D) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) Commission file no. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| November 8, 2019 |
LANNETT ANNOUNCES FISCAL 2020 FIRST-QUARTER FINANCIAL RESULTS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES FISCAL 2020 FIRST-QUARTER FINANCIAL RESULTS Financial and Business Highlights: · Net Sales, Profitability Exceeded Expectations · Launched First-to-Market Posaconazole · Expanded Pipeline with Significant Future Opportunities: · Levothyroxine (Approved) · Generic ADVAIR DISKUS® · Successfully Completed $86.25 |
|
| November 8, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): November 6, 2019 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| November 7, 2019 |
Sinotherapeutics Distribution and Supply Agreement Exhibit 10.59 CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. DISTRIBUTION AND SUPPLY AGREEMENT THIS DISTRIBUTION AND SUPPLY AGREEMENT (this “Agreement”) is made this 2nd day of August, 2019 (the “Effective Date”), by and between SI |
|
| November 7, 2019 |
our Quarterly Report on Form 10-Q filed on November 7, 2019. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2019 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-312 |
|
| November 7, 2019 |
Lannett Company, Inc. Non-Qualified Deferred Compensation Plan Exhibit 10.60 LANNETT COMPANY, INC. NON-QUALIFIED DEFERRED COMPENSATION PLAN Effective July 1, 2019 i LANNETT COMPANY, INC. NON QUALIFIED DEFERRED COMPENSATION PLAN NON-QUALIFIED DEFERRED COMPENSATION PLAN TABLE OF CONTENTS SECTION 1 INTRODUCTION 6 1.1 Introduction 6 1.2 Definitions 6 1.2.1 Account 6 1.2.2 Administrator 6 1.2.3 Affiliate 6 1.2.4 Annual Contribution Amount 6 1.2.5 Base Pay 6 1.2.6 |
|
| November 7, 2019 |
Exhibit 10.58 AGREEMENT BETWEEN LANNETT COMPANY, INC. and CEDIPROF, INC. Dated as of July 3, 2019 AGREEMENT THIS AGREEMENT (this “Agreement”) is entered into as of July 3, 2019 (the “Execution Date”), is between Lannett Company, Inc., a Delaware corporation located at 9000 State Road, Philadelphia, Pennsylvania 19136 and/or its Affiliates (“Lannett”) and Cediprof, Inc., a Puerto Rico corporation l |
|
| October 31, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): October 30, 2019 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R |
|
| October 31, 2019 |
LANNETT COMPANY, INC. NET SALES BY MEDICAL INDICATION Exhibit 99.1 LANNETT COMPANY, INC. NET SALES BY MEDICAL INDICATION Three months ended Twelve months ended ($ in thousands) September 30, 2018 December 31, 2018 March 31, 2019 June 30, 2019 June 30, 2019 Medical Indication Analgesic $ 1,829 $ 2,547 $ 946 $ 2,929 $ 8,251 Anti-Psychosis 10,889 14,036 20,616 27,912 73,453 Cardiovascular 21,770 25,680 22,783 31,234 101,467 Central Nervous System 14,286 |
|
| September 27, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 27, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I. |
|
| September 27, 2019 |
LANNETT ANNOUNCES CLOSING OF $86.25 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2026 Exhibit 99.1 Lannett Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES CLOSING OF $86.25 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2026 Philadelphia, PA — September 27, 2019 — Lannett Company, Inc. (NYSE: LCI) (“Lannett” or the “Company”) today announced the closing of $86.25 million aggregate principal amount of 4.50% convertible senior notes due 2026 (the “Notes”) in a p |
|
| September 27, 2019 |
Exhibit 4.5 EXECUTION VERSION LANNETT COMPANY, INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of September 27, 2019 4.50% Convertible Senior Notes due 2026 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01 . Definitions 1 Section 1.02 . References to Interest 10 ARTICLE 2 ISSUE, DESCRIPTION, EXECUTION, REGISTRATION AND EXCHANGE OF NOTES Section 2.01 . Design |
|
| September 27, 2019 |
Form of Capped Call Confirmations Exhibit 10.57 [ ] [ ], 2019 To: Lannett Company, Inc. 9000 State Road Philadelphia, PA 19136 Attention: John Kozlowski, Chief Financial Officer Telephone No.: (215) 333-9000 Re: [Base][Additional] Call Option Transaction The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [ ](“Dealer”), represented by |
|
| September 25, 2019 |
LANNETT ANNOUNCES PRICING OF $75 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2026 Exhibit 99.1 Lannett Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES PRICING OF $75 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2026 Philadelphia, PA — September 25, 2019 — Lannett Company, Inc. (NYSE: LCI) (“Lannett” or the “Company”) today announced the pricing of $75 million aggregate principal amount of 4.50% convertible senior notes due 2026 (the “Notes”) in a private |
|
| September 25, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I. |
|
| September 24, 2019 |
Exhibit 99.1 INVESTOR PRESENTATION September 2019 © 2019 Lannett Company, Inc. All Rights Reserved. For Discussion Purposes Only Cautionary Statements This presentation contains forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regarding our future results of operations and financial position, business strategy |
|
| September 24, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I. |
|
| September 24, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I. |
|
| September 24, 2019 |
LANNETT ANNOUNCES OFFERING OF $75 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2026 Exhibit 99.1 Lannett Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES OFFERING OF $75 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2026 Philadelphia, PA — September 24, 2019 — Lannett Company, Inc. (NYSE: LCI) today announced that it intends to offer, subject to market conditions and other factors, $75 million aggregate principal amount of convertible senior notes due 2026 ( |
|
| August 28, 2019 |
Form 10-K for the fiscal year ended June 30, 2019 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 OR o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-31298 LANNETT COMPANY, |
|
| August 28, 2019 |
Description of Capital Stock of Lannett Company, Inc. EXHIBIT 4.4 DESCRIPTION OF CAPITAL STOCK OF LANNETT COMPANY, INC. The following description of the general terms and provisions of our common stock is a summary only and therefore is not complete and is subject to, and qualified in its entirety by reference to, the terms and provisions of our certificate of incorporation and our bylaws. Our certificate of incorporation and our bylaws have previous |
|
| August 28, 2019 |
Exhibit 21.1 Subsidiaries of the Company The following list identifies the subsidiaries of the Company: Subsidiary Name State of Incorporation Lannett Holdings, Inc. Delaware Cody Laboratories, Inc. Wyoming Silarx Pharmaceuticals, Inc. New York Kremers Urban Pharmaceuticals, Inc. Indiana 1 |
|
| August 28, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): August 27, 2019 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R. |
|
| August 28, 2019 |
Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES FISCAL 2019 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS; ISSUES GUIDANCE FOR FISCAL 2020 Fiscal 2019 Fourth Quarter Highlights: · Net Sales of $134 Million Exceeds Expectations · Adjusted Gross Margin Percentage Highest of Any Quarter in Fiscal 2019 · Voluntarily Purchased Additional $38 Million of Term A Loa |
|
| August 27, 2019 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S |
|
| August 9, 2019 |
Exhibit 3 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned Reporting Persons hereby agrees to the joint filing, along with all other such Reporting Persons, on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0. |
|
| August 9, 2019 |
Exhibit 1 POWER OF ATTORNEY FOR CERTAIN REGULATORY FILINGS INCLUDING CERTAIN FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND THE INVESTMENT ADVISERS ACT OF 1940 I, David E. |
|
| August 9, 2019 |
Exhibit 2 POWER OF ATTORNEY FOR CERTAIN REGULATORY FILINGS INCLUDING CERTAIN FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND THE INVESTMENT ADVISERS ACT OF 1940 I, David E. |
|
| August 9, 2019 |
LCI / Lannett Co., Inc. / D. E. SHAW & CO, L.P. - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 2) Under the Securities Exchange Act of 1934 Lannett Company, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 516012101 (CUSIP Number) July 30, 2019 (Date of Event Which Requires Filing of this Statement) Check the following box to designate the rule pursuant to which the Sched |
|
| August 1, 2019 |
Second Amendment to Restated Employment Agreement of John Kozlowski, dated as of July 31, 2019 EX-10.56 2 a19-164441ex10d56.htm EX-10.56 EXHIBIT 10.56 SECOND AMENDMENT TO RESTATED EMPLOYMENT AGREEMENT OF JOHN KOZLOWSKI THIS SECOND AMENDMENT (the “Second Amendment”) to the Restated Employment Agreement (as defined below) is made and entered into as of July 31, 2019 (the “Second Amendment Effective Date”) by and between John Kozlowski (“Executive”) and Lannett Company, Inc. (“Company”). WHERE |
|
| August 1, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| August 1, 2019 |
LANNETT APPOINTS JOHN KOZLOWSKI CFO Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT APPOINTS JOHN KOZLOWSKI CFO Philadelphia, PA — August 1, 2019 — Lannett Company, Inc. (NYSE: LCI) today announced the appointment of John Kozlowski as chief financial officer (CFO), effective August 31, 2019. He succeeds Martin Galvan, who, as previously announced, will retire on August 30, 2019, following the planned |
|
| July 8, 2019 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 3, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. E |
|
| July 8, 2019 |
LANNETT ENTERS INTO DISTRIBUTION AGREEMENT FOR LEVOTHYROXINE EX-99.1 2 a19-125621ex99d1.htm EX-99.1 Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ENTERS INTO DISTRIBUTION AGREEMENT FOR LEVOTHYROXINE Philadelphia, PA — July 8, 2019 — Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP of Cediprof, Inc |
|
| June 17, 2019 |
Material Impairments, Costs Associated with Exit or Disposal Activities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| May 24, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. E |
|
| May 24, 2019 |
LANNETT ANNOUNCES CFO RETIREMENT Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES CFO RETIREMENT Philadelphia, PA — May 24, 2019 — Lannett Company, Inc. (NYSE: LCI) today announced that the company’s chief financial officer (CFO), Martin Galvan, 67, will retire on August 30, 2019, following the planned submission of the company’s Form 10-K for fiscal year 2019. Galvan will continue in his |
|
| May 24, 2019 |
Exhibit 10.55 SEPARATION AGREEMENT AND GENERAL RELEASE THIS SEPARATION AGREEMENT AND GENERAL RELEASE (hereinafter referred to as the “Agreement”) is made and entered into by and between Martin Galvan (as used herein, “Executive” includes Martin Galvan and his legal representatives, agents, heirs, executors, administrators, successors and assigns), and Lannett Company, Inc., its divisions, parents, |
|
| May 23, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) COMMISSION FILE NO. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. E |
|
| May 23, 2019 |
LANNETT APPOINTS MELISSA V. REWOLINSKI, PHD, TO BOARD OF DIRECTORS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT APPOINTS MELISSA V. REWOLINSKI, PHD, TO BOARD OF DIRECTORS Philadelphia, PA — May 23, 2019 — Lannett Company, Inc. (NYSE: LCI) today announced the appointment of Melissa V. Rewolinski, PhD, to its board of directors, effective July 1, 2019. Following the appointment of Dr. Rewolinski, the board will comprise eight dire |
|
| May 21, 2019 |
LANNETT PURCHASES ADDITIONAL $30.5 MILLION OF TERM A LOANS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT PURCHASES ADDITIONAL $30.5 MILLION OF TERM A LOANS Philadelphia, PA — May 21, 2019 — Lannett Company, Inc. (NYSE: LCI) today announced that it completed the purchase of approximately $30.5 million, face value, of its Term A Loans in a private transaction. “We are particularly pleased to use our strong cash position to |
|
| May 21, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): May 20, 2019 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. |
|
| May 7, 2019 |
LANNETT ANNOUNCES FISCAL 2019 THIRD-QUARTER FINANCIAL RESULTS; RAISES GUIDANCE FOR FISCAL 2019 Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT ANNOUNCES FISCAL 2019 THIRD-QUARTER FINANCIAL RESULTS; RAISES GUIDANCE FOR FISCAL 2019 · Net Sales, Excluding Levothyroxine, Continues Sequential Quarterly Growth · 4 New Product Launches in the Quarter; More Launches Expected in Q4 · Cost Reduction Program Nearly Complete · Cash Balance of $205 Million at March 31, Af |
|
| May 7, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): May 6, 2019 LANNETT COMPANY, INC. (Exact Name of Registrant as Specified in Its Charter) Commission File No. 001-31298 State of Delaware 23-0787699 (State of Incorporation) (I.R.S. E |
|
| May 7, 2019 |
LCI / Lannett Co., Inc. 10-Q Quarterly Report 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2019 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-31298 L |
|
| March 22, 2019 |
As filed with the Securities and Exchange Commission on March 22, 2019 Registration No. |
|
| March 21, 2019 |
LANNETT PURCHASES $24 MILLION OF TERM LOANS IN OPEN MARKET TRANSACTIONS Exhibit 99.1 Contact: Robert Jaffe Robert Jaffe Co., LLC (424) 288-4098 LANNETT PURCHASES $24 MILLION OF TERM LOANS IN OPEN MARKET TRANSACTIONS Philadelphia, PA — March 21, 2019 — Lannett Company, Inc. (NYSE: LCI) today announced that it completed the purchase of approximately $24.2 million principal amount of its Term Loans in open market transactions. The purchases comprised approximately $8.0 m |
|
| March 21, 2019 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 21, 2019 LANNETT COMPANY, INC. (Exact name of registrant as specified in its charter) Delaware 001-31298 23-0787699 (State of Incorporation) (Commission File Number) (IRS Employ |
|
| February 25, 2019 |
Exhibit 2 POWER OF ATTORNEY FOR CERTAIN REGULATORY FILINGS INCLUDING CERTAIN FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND THE INVESTMENT ADVISERS ACT OF 1940 I, David E. |
|
| February 25, 2019 |
EX-99.3 4 tv514621ex-3.htm EXHIBIT 3 Exhibit 3 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned Reporting Persons hereby agrees to the joint filing, along with all other such Reporting Persons, on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common St |
|
| February 25, 2019 |
LCI / Lannett Co., Inc. / D. E. SHAW & CO, L.P. - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 Lannett Company, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 516012101 (CUSIP Number) February 15, 2019 (Date of Event Which Requires Filing of this Statement) Check the following box to designate the rule pursuant to which the S |
|
| February 25, 2019 |
Exhibit 1 POWER OF ATTORNEY FOR CERTAIN REGULATORY FILINGS INCLUDING CERTAIN FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND THE INVESTMENT ADVISERS ACT OF 1940 I, David E. |
|
| February 12, 2019 |
LCI / Lannett Co., Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
